Winthrop Advisory Group LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,301 shares of the healthcare conglomerate’s stock after acquiring an additional 31 shares during the period. Winthrop Advisory Group LLC’s holdings in UnitedHealth Group were worth $658,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp lifted its stake in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after buying an additional 563,554 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after buying an additional 318,039 shares in the last quarter. Franklin Resources Inc. lifted its stake in UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares in the last quarter. International Assets Investment Management LLC lifted its stake in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. 87.86% of the stock is owned by institutional investors.
UnitedHealth Group Stock Up 4.1 %
Shares of NYSE UNH traded up $21.59 during midday trading on Monday, hitting $542.28. The stock had a trading volume of 1,345,160 shares, compared to its average volume of 3,737,545. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $555.25 and its 200-day moving average is $562.50. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market cap of $499.05 billion, a P/E ratio of 35.33, a PEG ratio of 1.53 and a beta of 0.62.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.
Wall Street Analyst Weigh In
Several equities analysts recently commented on UNH shares. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, December 9th. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Two analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $626.79.
Get Our Latest Research Report on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Why Invest in High-Yield Dividend Stocks?
- Delta Can Fly to New Highs in 2025; Here’s Why
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
- Election Stocks: How Elections Affect the Stock Market
- 3 Dividend Stocks With Growth Potential You Can’t Miss
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.